News Archive

Date: 10/18/2016
A transcription factor known as Snail1 can act as a “molecular bypass” that diminishes the natural tumor suppressing action of a gene called p53 in breast cancer patients, a new study finds.
Date: 10/17/2016
As part of the Cancer Moonshot, representatives from government, academic, pharmaceutical and diagnostic companies are launching a new partnership in pursuit of creating an open database for liquid biopsies to potentially accelerate the development of safe and effective blood profiling diagnostic technologies for patient benefit.
Date: 10/04/2016
The University of Michigan Comprehensive Cancer Center is one of 12 sites to join Precision Promise, the first large-scale precision medicine trial designed to transform outcomes for patients with pancreatic cancer.
Date: 09/27/2016
The University of Michigan Comprehensive Cancer Center has appointed four new leaders to oversee the direction and operation of its research enterprise.
Date: 09/23/2016
The technique could one day help screen potential cancer treatments based on an individual patient's tumor and help researchers better understand cancer stem cells.
Date: 09/16/2016
Eric Fearon, M.D., Ph.D., has been named director of the University of Michigan Comprehensive Cancer Center.
Date: 09/15/2016
A small device implanted under the skin can improve breast cancer survival by catching cancer cells, slowing the growth of tumors.
Date: 08/04/2016
U.S. News & World Report rankings places the U-M Comprehensive Cancer Center ranks first in Michigan.
Date: 08/01/2016
Women who engaged on social media after a breast cancer diagnosis expressed more deliberation about their treatment decision and more satisfaction with the path they chose, a new study finds.
Date: 07/29/2016
More imaging after thyroid cancer treatment identifies recurrence, but it does not always improve survival, a new study suggests.